by Kharrazian Institute | Aug 19, 2026 | Blog, Chronic Infections
Most practitioners are trained to treat infections acutely and move on. The deeper clinical problem is what happens when the infection never fully resolves — or when a latent pathogen reactivates months or years later, and the immune system response it triggers begins...
by Kharrazian Institute | Aug 18, 2026 | Blog, Longevity
Most practitioners ordering longevity panels are measuring the wrong things. Telomere length, inflammatory markers, and lipid oxidation panels tell you something about aging — but they don’t tell you why the cell is failing. Mitochondrial health longevity...
by KI | Aug 17, 2026 | Blog, Longevity
Most aging protocols treat hormones, inflammation, and neurological decline as separate problems requiring separate interventions. That diagnostic habit is the core reason so many aging patients plateau. The nervous system, endocrine system, and immune system do not...
by Kharrazian Institute | Aug 16, 2026 | Blog, Mood and Anxiety
A common practitioner mistake is treating anxiety and depression as isolated neurological events while metabolic dysfunction drives the entire presentation. When a patient’s mood symptoms don’t respond to standard interventions, blood sugar dysregulation...
by Kharrazian Institute | Aug 15, 2026 | Blog, Mood and Anxiety
The serotonin hypothesis of depression has driven psychiatric treatment for decades. It has also produced a patient population that takes SSRIs indefinitely, never fully recovers, and cycles through medication adjustments while the underlying physiology goes...
by Kharrazian Institute | Aug 14, 2026 | Blog, Mood and Anxiety
Most practitioners treating depression are still asking one question: which neurotransmitter is deficient? Research in neuroimmunology has been asking a different one for years: which inflammatory pathway is active? The clinical gap between those two questions is...
